PhosphoSolutions

PhosphoSolutions is a specialized biotechnology company focused on the design and manufacture of high-quality antibodies for neuroscience and cell signaling research. Founded in 2001 by pioneers in the field of protein phosphorylation, the company is renowned for its expertise in creating phosphospecific antibodies that allow researchers to study protein regulation. Their product portfolio includes thousands of primary antibodies, with a particular emphasis on targets related to synaptic plasticity, neurodegeneration, and neurotransmission. In 2024, PhosphoSolutions was acquired by Bio-Techne, integrating its specialized catalog into a broader life sciences portfolio. The company continues to operate as a key provider of validated reagents for the global scientific community.